The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells
Open accessAbstract
BACKGROUND: Corticosteroids are commonly used to treat infantile hemangioma, but the mechanism of action of this therapy is unknown. We investigated the effect of corticosteroids in a previously described in vivo model of infantile hemangioma and in cultured hemangioma-derived cells. METHODS: We tested hemangioma-derived stem cells for vasculogenic activity in vivo after implantation into immune-deficient (nude) mice. We studied dexamethasone treatment of both the cells before implantation and the mice after implantation. We also tested hemangioma-derived stem cells for expression of vascular endothelial growth factor A (VEGF-A) in vitro and studied the inhibition of VEGF-A expression, using short hairpin RNA (shRNA) in vivo and in vitro. RESULTS: Systemic treatment with dexamethasone led to dose-dependent inhibition of tumor vasculogenesis in the murine model. Pretreatment of hemangioma-derived stem cells in vitro before implantation also inhibited vasculogenesis. Dexamethasone suppressed VEGF-A production by hemangioma-derived stem cells in vitro but not by hemangioma-derived endothelial cells or human umbilical-vein endothelial cells. Silencing VEGF-A in hemangioma-derived stem cells reduced vasculogenesis in vivo. VEGF-A was detected in hemangioma specimens in the proliferating phase but not in the involuting phase and was shown by immunostaining to reside outside of vessels. Corticosteroid treatment suppressed other proangiogenic factors in hemangioma-derived stem cells, including urokinase plasminogen activator receptor, interleukin-6, monocyte chemoattractant protein 1, and matrix metalloproteinase 1. CONCLUSIONS: In a murine model, dexamethasone inhibited the vasculogenic potential of stem cells derived from human infantile hemangioma. The corticosteroid also inhibited the expression of VEGF-A by hemangioma-derived stem cells, and silencing of VEGF-A expression in these cells inhibited vasculogenesis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hemangiomas and Vascular Malformations in Infants and Children
Mulliken, J. B., & Glowacki, J. (1982) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198203000-00002 · Cited by 3,322
Self-citationCellular markers that distinguish the phases of hemangioma during infancy and childhood.
Takahashi, K., Mulliken, J. B., Kozakewich, H. P., Rogers, R. A., Folkman, J., & Ezekowitz, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117241 · Cited by 648
Self-citationDrolet, B. A., Esterly, N. B., & Frieden, I. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410307 · Cited by 586
Mulliken, J. B., Fishman, S. J., & Burrows, P. E. (2000) · Current Problems in Surgery · doi:10.1016/s0011-3840(00)80013-1 · Cited by 504
Self-citationIn vivo vasculogenic potential of human blood-derived endothelial progenitor cells
Melero-Martin, J. M., Khan, Z. A., Picard, A., Wu, X., Paruchuri, S., & Bischoff, J. (2007) · Blood · doi:10.1182/blood-2006-12-062471 · Cited by 501
Self-citationNauck, M., Karakiulakis, G., Perruchoud, A. P., Papakonstantinou, E., & Roth, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01464-7 · Cited by 479
Jinnin, M., Medici, D., Park, L., Limaye, N., Liu, Y., Boscolo, E., Bischoff, J., Vikkula, M., Boye, E., & Olsen, B. R. (2008) · Nature Medicine · doi:10.1038/nm.1877 · Cited by 370
Self-citationZacharchuk, C. M., Merćep, M., Chakraborti, P. K., Simons, S. S., & Ashwell, J. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4037 · Cited by 309
Clonality and altered behavior of endothelial cells from hemangiomas
Boye, E., Yu, Y., Paranya, G., Mulliken, J. B., Olsen, B. R., & Bischoff, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11432 · Cited by 298
Self-citationMultipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice
Khan, Z. A., Boscolo, E., Picard, A., Psutka, S., Melero-Martin, J. M., Bartch, T. C., Mulliken, J. B., & Bischoff, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33493 · Cited by 294
Self-citation
Cited by
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 590
Self-citationStorch, C. H., & Hoeger, P. H. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09848.x · Cited by 526
Tao, S.-C., Yuan, T., Rui, B.-Y., Zhu, Z.-Z., Guo, S.-C., & Zhang, C.-Q. (2017) · Theranostics · doi:10.7150/thno.17450 · Cited by 346
Diagnosis and Management of Infantile Hemangioma
Darrow, D. H., Greene, A. K., Mancini, A. J., Nopper, A. J., the SECTION ON DERMATOLOGY, S. O. O. A. N. S., Antaya, R. J., Cohen, B., Drolet, B. A., Fay, A., Fishman, S. J., et al. (2015) · Pediatrics · doi:10.1542/peds.2015-2485 · Cited by 293
Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide
Isung, J., Mobarrez, F., Nordström, P., Åsberg, M., & Jokinen, J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.624549 · Cited by 94
Metadata
- Authors
- Greenberger, S., Boscolo, E., Adini, I., Mulliken, J. B., & Bischoff, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-18
- Volume
- 362
- Issue
- 11
- Pages
- 1005-1013
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2081913946
- Cited by
- 275
- References
- 25
- FWCI
- 26.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells. https://app.cochat.ai/papers/10.1056/nejmoa0903036
- The paper
- Greenberger, S., Boscolo, E., Adini, I., Mulliken, J. B., & Bischoff, J. (2010). Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells. New England Journal of Medicine. https://doi.org/10.1056/nejmoa0903036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.